Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.35M Sell
103,430
-1,189,962
-92% -$72.8M 0.03% 210
2026
Q1
$89.8M Buy
1,293,392
+52,692
+4% +$4.06M 0.47% 61
2025
Q4
$94.4M Buy
1,240,700
+14,640
+1% +$1.18M 0.44% 51
2025
Q3
$106M Sell
1,226,060
-891,802
-42% -$67.3M 0.5% 43
2025
Q2
$144M Buy
2,117,862
+147,098
+7% +$9.11M 0.73% 31
2025
Q1
$117M Buy
+1,970,764
New +$125M 0.66% 42
2024
Q4
Sell
-99,640
Closed -$7.18M 222
2024
Q3
$7.18M Buy
+99,640
New +$6.96M 0.04% 135

Other funds holding APTV

AustralianSuper's APTV Position: Q2 2026 in Review

AustralianSuper reduced its Aptiv (APTV) stake by 92% in Q2 2026, selling an estimated $72.8M and leaving 103,430 shares worth $6.35M. The position accounts for 0.03% of the portfolio, ranked #210.

AustralianSuper first reported a position in APTV in Q3 2024 and has held it in 7 quarters since. The position peaked at $144M in Q2 2025. 657 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • AustralianSuper held 103,430 shares of Aptiv worth $6.35M as of Q2 2026.
  • AustralianSuper sold 1,189,962 Aptiv shares in Q2 2026, an estimated $72.8M.
  • Aptiv made up 0.03% of AustralianSuper's portfolio in Q2 2026, its #210 holding.
  • AustralianSuper first reported a position in Aptiv in Q3 2024 and has held it in 7 quarters since.
  • AustralianSuper's Aptiv position peaked at $144M in Q2 2025.
  • 657 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.